Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Clinical trial NCT02580747 · UNKNOWN

Trial details

NCT number: NCT02580747
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Mesothelioma Pancreatic Cancer Ovarian Tumor Triple Negative Breast Cancer Endometrial Cancer Other Mesothelin Positive Tumors

Start date: 2015-10-01
Primary completion: 2017-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.